Sort
48,018 grants matching “immunotherapy”
Project 1: Glutaminolytic GDH1 activation-dependent immunotherapy resistance in LKB1-mutant lung adenocarcinoma
$416,967Sumin Kang · Emory University · P01 · FY2023 · CA
Targeting ovarian cancer spheroid formation and metabolic adaptation by APJ inhibition
$416,950Sukyung Woo · State University Of New York At Buffalo · R01 · FY2022 · CA
(PQ 6) New Models of KSHV Oncogenesis and KS Immune Environment
$416,939Ethel Cesarman · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · CA
(PQ 6) New Models of KSHV Oncogenesis and KS Immune Environment
$416,939Ethel Cesarman · Weill Medical Coll Of Cornell Univ · R01 · FY2020 · CA
(PQ 6) New Models of KSHV Oncogenesis and KS Immune Environment
$416,939Ethel Cesarman · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · CA
(PQ 6) New Models of KSHV Oncogenesis and KS Immune Environment
$416,939Ethel Cesarman · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · CA
(PQ 6) New Models of KSHV Oncogenesis and KS Immune Environment
$416,939Ethel Cesarman · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · CA
Intravesical Chitosan/IL-12 Immunotherapy for Bladder Carcinoma
$416,897David Zaharoff · University Of Arkansas At Fayetteville · R15 · FY2014 · CA
Multiple Approaches to Abeta Vaccination in Animal Models
$416,848David Hastings Cribbs · University Of California-Irvine · R01 · FY2006 · AG
A Multi-Epitope Vaccine for NSCLC and Colon Cancer
$416,823Idm Pharma, Inc. · R21 · FY2005 · CA
Improving CAR-T cell therapy in metastatic breast cancers by reprogramming obesity-aggravated tumor microenvironment via physical activity
$416,818Dai Fukumura · Massachusetts General Hospital · R21 · FY2025 · CA
Effects of Complement on the Tumor Microenvironment in Lung Cancer
$416,813Raphael A. Nemenoff · University Of Colorado Denver · R01 · FY2019 · CA
Project 3 Immunotherapeutic Targeting of SLC45A2 for Treatment of Uveal Melanoma
$416,787Cassian Yee · University Of Tx Md Anderson Can Ctr · P50 · FY2019 · CA
Project 3 Immunotherapeutic Targeting of SLC45A2 for Treatment of Uveal Melanoma
$416,783Cassian Yee · University Of Tx Md Anderson Can Ctr · P50 · FY2022 · CA
Tracking Therapy-Resistant Alterations in Childhood Acute Lymphoblastic Leukemia
$416,766Xiaotu Ma · St. Jude Children'S Research Hospital · R01 · FY2023 · CA
Cocaine Vaccine for Methadone Maintained Patients
$416,756Yale University · R01 · FY2003 · DA
SOUTHWEST ONCOLOGY GROUP--SUMMARY
$416,726Loyola University Chicago · U10 · FY2002 · CA
HER3-PHF8 signaling axis in triple-negative breast cancer progression
$416,723Bolin Liu · Lsu Health Sciences Center · R01 · FY2023 · CA
Antibodies as Catalysts
$416,700Scripps Research Institute · R01 · FY2004 · GM
Antibodies as Catalysts
$416,700Scripps Research Institute · R01 · FY2003 · GM
NOVEL STRATEGIES FOR THE IMMUNOTHERAPY OF COLON CANCER
$416,700Scripps Research Institute · R01 · FY2003 · CA
Antibodies as Catalysts
$416,700Scripps Research Institute · R01 · FY2002 · GM
NOVEL STRATEGIES FOR THE IMMUNOTHERAPY OF COLON CANCER
$416,700Scripps Research Institute · R01 · FY2002 · CA
Pathogenesis of microbial anterior eye diseases
$416,677Gerald B Pier · Brigham And Women'S Hospital · R01 · FY2015 · EY
Genetic Mechanisms Controlling Kidney Cancer Immune Escape
$416,677Haydn Kissick · Emory University · R01 · FY2025 · CA